These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 104795)

  • 21. [The effect of vaccination on local immunity indices; the determination of antimeningococcal antibodies in saliva].
    Martynov IuV; Marinin IIu; Deviatkina NN
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):55-8. PubMed ID: 1801492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of the reactogenicity and immunogenicity of various doses of a chemical polysaccharide meningococcal vaccine administered by syringe and jet injector].
    Pavlova LI; Nefedova LA; Nikitiuk NM; Chernysheva TF; Alliluev AP
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):58-64. PubMed ID: 6419514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of meningococcal antibodies by a radial hemolysis method].
    Martynov IuV; Samsonova IM; Demina AA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):27-30. PubMed ID: 6441396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Method of setting up the bacterial lysis reaction of Neisseria meningitidis strains].
    Kuzikov AN; Shmeleva EA; Baranova GV; Mitkovetskiĭ VI; Lifanova II
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Oct; (10):25-8. PubMed ID: 3937387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sickle cell trait and the immune response to meningococcal vaccines.
    Blakebrough IS; Greenwood BM; Whittle HC; Bradley AK; Akintunde A
    Trans R Soc Trop Med Hyg; 1981; 75(6):905-6. PubMed ID: 6800076
    [No Abstract]   [Full Text] [Related]  

  • 26. Responses to tuberculin and meningococcal polysaccharide vaccination during ageing in Nigerians.
    Oyeyinka GO; Salimonu LS; Balogun B; Idowu JR
    Ann Trop Med Parasitol; 1995 Jun; 89(3):317-20. PubMed ID: 7668925
    [No Abstract]   [Full Text] [Related]  

  • 27. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 28. Determination of meningococcal antibodies by microassay.
    Ambrosch F; Stemberger H; Wiedermann G; Stanek G; Jovanovic D
    Bull World Health Organ; 1978; 56(5):787-90. PubMed ID: 104795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunity against Neisseria meningitidis in different population groups].
    Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
    Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
    Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
    Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.
    Ambrosch F; Wiedermann G; Crooy P; George AM
    Bull World Health Organ; 1983; 61(2):317-23. PubMed ID: 6407768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meningococcal infections. 4. Stability of group A and group C polysaccharide vaccines.
    Artenstein MS
    Bull World Health Organ; 1971; 45(3):287-90. PubMed ID: 5316909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.
    Gold R; Lepow ML; Goldschneider I; Draper TL; Gotschlich EC
    J Clin Invest; 1975 Dec; 56(6):1536-47. PubMed ID: 1202084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and laboratory investigations of monovalent and combined meningococcal polysaccharide vaccine, groups A and C.
    Weibel RE; Villarejos VM; Vella PP; Woodhour AF; Mclean AA; Hilleman MR
    Proc Soc Exp Biol Med; 1976 Dec; 153(3):436-40. PubMed ID: 827748
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.